Table 2.
Characteristics | Hazard Ratio | 95% CI | P Value |
---|---|---|---|
Crude | |||
Control | Reference | ||
COPD | 0.927 | 0.564–1.524 | 0.765 |
CPFE | 2.853 | 1.343–6.062 | 0.006 |
IPF | 4.344 | 2.301–8.201 | <0.001 |
Model 1 | |||
Control | Reference | ||
COPD | 1.326 | 0.725–2.425 | 0.360 |
CPFE | 3.034 | 1.328–6.931 | 0.009 |
IPF | 4.246 | 2.060–8.753 | <0.001 |
Model 2 | |||
Control | Reference | ||
COPD | 1.306 | 0.723–2.358 | 0.376 |
CPFE | 3.382 | 1.472–7.769 | 0.004 |
IPF | 4.061 | 1.963–8.403 | <0.001 |
Notes: Model 1 adjusted for age, smoking status, performance status (ECOG ≤ 1 or ≥ 2), clinical stage (clinical stage I or II), FEV1≤ 80% pred and DLco≤ 60% pred. Model 2 adjusted for age, smoking status, performance status (ECOG ≤ 1 or ≥ 2), clinical stage (clinical stage I or II), FEV1≤ 80% pred, DLco≤ 60% pred and Radiotherapy technique.
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; CPFE, combined pulmonary fibrosis and emphysema; IPF, idiopathic pulmonary fibrosis.